JB CHEMICALS & PHARMACEUTICALS
|
JB CHEMICALS & PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
Equity - Authorised | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr |
Equity - Issued | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
Equity Paid Up | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
Share Warrants & Outstandings | ₹140 Cr | ₹122 Cr | ₹63 Cr | - | - |
Total Reserves | ₹2,768 Cr | ₹2,343 Cr | ₹2,056 Cr | ₹1,794 Cr | ₹1,420 Cr |
Securities Premium | ₹113 Cr | ₹70 Cr | ₹51 Cr | ₹51 Cr | ₹51 Cr |
Capital Reserves | ₹-0.04 Cr | ₹-0.04 Cr | ₹0.68 Cr | ₹0.68 Cr | ₹0.68 Cr |
Profit & Loss Account Balance | ₹2,517 Cr | ₹2,125 Cr | ₹1,843 Cr | ₹1,585 Cr | ₹1,223 Cr |
General Reserves | ₹151 Cr | ₹130 Cr | ₹130 Cr | ₹130 Cr | ₹130 Cr |
Other Reserves | ₹-13 Cr | ₹18 Cr | ₹31 Cr | ₹28 Cr | ₹15 Cr |
Reserve excluding Revaluation Reserve | ₹2,768 Cr | ₹2,343 Cr | ₹2,056 Cr | ₹1,794 Cr | ₹1,420 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹2,923 Cr | ₹2,480 Cr | ₹2,134 Cr | ₹1,810 Cr | ₹1,435 Cr |
Minority Interest | - | - | ₹4.49 Cr | ₹3.71 Cr | ₹2.50 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹24 Cr | ₹383 Cr | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹342 Cr | ₹520 Cr | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-318 Cr | ₹-137 Cr | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹143 Cr | ₹96 Cr | ₹41 Cr | ₹50 Cr | ₹48 Cr |
Deferred Tax Assets | ₹22 Cr | ₹18 Cr | ₹19 Cr | ₹22 Cr | ₹16 Cr |
Deferred Tax Liability | ₹166 Cr | ₹114 Cr | ₹60 Cr | ₹72 Cr | ₹64 Cr |
Other Long Term Liabilities | ₹11 Cr | ₹18 Cr | ₹24 Cr | ₹10 Cr | ₹7.20 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹288 Cr | ₹495 Cr | ₹410 Cr | ₹13 Cr | ₹7.39 Cr |
Total Non-Current Liabilities | ₹466 Cr | ₹992 Cr | ₹475 Cr | ₹72 Cr | ₹63 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹356 Cr | ₹239 Cr | ₹224 Cr | ₹187 Cr | ₹168 Cr |
Sundry Creditors | ₹356 Cr | ₹239 Cr | ₹224 Cr | ₹187 Cr | ₹168 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹436 Cr | ₹240 Cr | ₹81 Cr | ₹90 Cr | ₹103 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹13 Cr | ₹12 Cr | ₹4.32 Cr | ₹4.23 Cr | ₹21 Cr |
Interest Accrued But Not Due | - | ₹0.03 Cr | ₹0.01 Cr | ₹0.00 Cr | ₹0.02 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹423 Cr | ₹228 Cr | ₹77 Cr | ₹86 Cr | ₹81 Cr |
Short Term Borrowings | ₹15 Cr | ₹28 Cr | ₹26 Cr | ₹33 Cr | ₹29 Cr |
Secured ST Loans repayable on Demands | ₹15 Cr | ₹28 Cr | ₹26 Cr | ₹33 Cr | ₹29 Cr |
Working Capital Loans- Sec | ₹15 Cr | ₹28 Cr | ₹26 Cr | ₹33 Cr | ₹29 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-15 Cr | ₹-28 Cr | ₹-26 Cr | ₹-33 Cr | ₹-29 Cr |
Short Term Provisions | ₹480 Cr | ₹119 Cr | ₹123 Cr | ₹377 Cr | ₹216 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹431 Cr | ₹76 Cr | ₹78 Cr | ₹349 Cr | ₹209 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹49 Cr | ₹43 Cr | ₹46 Cr | ₹28 Cr | ₹7.11 Cr |
Total Current Liabilities | ₹1,288 Cr | ₹626 Cr | ₹455 Cr | ₹687 Cr | ₹516 Cr |
Total Liabilities | ₹4,677 Cr | ₹4,098 Cr | ₹3,069 Cr | ₹2,572 Cr | ₹2,017 Cr |
ASSETS | |||||
Gross Block | ₹2,835 Cr | ₹2,608 Cr | ₹1,876 Cr | ₹1,183 Cr | ₹1,177 Cr |
Less: Accumulated Depreciation | ₹831 Cr | ₹707 Cr | ₹599 Cr | ₹549 Cr | ₹526 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹2,004 Cr | ₹1,901 Cr | ₹1,277 Cr | ₹634 Cr | ₹651 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹63 Cr | ₹44 Cr | ₹14 Cr | ₹26 Cr | ₹16 Cr |
Non Current Investments | ₹24 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr | ₹69 Cr |
Long Term Investment | ₹24 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr | ₹69 Cr |
Quoted | - | - | - | - | ₹57 Cr |
Unquoted | ₹24 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Long Term Loans & Advances | ₹294 Cr | ₹514 Cr | ₹435 Cr | ₹5.62 Cr | ₹3.59 Cr |
Other Non Current Assets | ₹6.03 Cr | ₹15 Cr | ₹1.04 Cr | ₹0.82 Cr | ₹0.36 Cr |
Total Non-Current Assets | ₹2,404 Cr | ₹2,499 Cr | ₹1,745 Cr | ₹679 Cr | ₹741 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹365 Cr | ₹192 Cr | - | ₹665 Cr | ₹334 Cr |
Quoted | ₹365 Cr | ₹192 Cr | - | ₹665 Cr | ₹334 Cr |
Unquoted | - | - | - | - | - |
Inventories | ₹503 Cr | ₹430 Cr | ₹410 Cr | ₹347 Cr | ₹275 Cr |
Raw Materials | ₹196 Cr | ₹166 Cr | ₹152 Cr | ₹129 Cr | ₹95 Cr |
Work-in Progress | ₹24 Cr | ₹36 Cr | ₹19 Cr | ₹24 Cr | ₹22 Cr |
Finished Goods | ₹109 Cr | ₹123 Cr | ₹132 Cr | ₹138 Cr | ₹90 Cr |
Packing Materials | ₹41 Cr | ₹46 Cr | ₹50 Cr | ₹29 Cr | ₹31 Cr |
Stores  and Spare | ₹0.76 Cr | ₹0.79 Cr | ₹0.78 Cr | ₹0.41 Cr | ₹0.43 Cr |
Other Inventory | ₹132 Cr | ₹58 Cr | ₹56 Cr | ₹27 Cr | ₹36 Cr |
Sundry Debtors | ₹687 Cr | ₹576 Cr | ₹556 Cr | ₹389 Cr | ₹345 Cr |
Debtors more than Six months | ₹22 Cr | ₹23 Cr | ₹36 Cr | ₹19 Cr | ₹0.27 Cr |
Debtors Others | ₹680 Cr | ₹558 Cr | ₹524 Cr | ₹375 Cr | ₹345 Cr |
Cash and Bank | ₹96 Cr | ₹79 Cr | ₹59 Cr | ₹31 Cr | ₹31 Cr |
Cash in hand | ₹0.03 Cr | ₹0.04 Cr | ₹0.09 Cr | ₹0.13 Cr | ₹0.23 Cr |
Balances at Bank | ₹96 Cr | ₹79 Cr | ₹44 Cr | ₹28 Cr | ₹31 Cr |
Other cash and bank balances | - | - | ₹15 Cr | ₹2.43 Cr | ₹0.10 Cr |
Other Current Assets | ₹33 Cr | ₹45 Cr | ₹57 Cr | ₹46 Cr | ₹19 Cr |
Interest accrued on Investments | ₹0.51 Cr | ₹0.39 Cr | ₹0.04 Cr | ₹0.04 Cr | ₹0.07 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹16 Cr | ₹17 Cr | ₹12 Cr | ₹12 Cr | ₹7.98 Cr |
Other current_assets | ₹16 Cr | ₹28 Cr | ₹45 Cr | ₹34 Cr | ₹11 Cr |
Short Term Loans and Advances | ₹590 Cr | ₹277 Cr | ₹243 Cr | ₹416 Cr | ₹272 Cr |
Advances recoverable in cash or in kind | ₹11 Cr | ₹14 Cr | ₹31 Cr | ₹3.71 Cr | ₹14 Cr |
Advance income tax and TDS | ₹420 Cr | ₹71 Cr | ₹71 Cr | ₹358 Cr | ₹219 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹159 Cr | ₹192 Cr | ₹140 Cr | ₹54 Cr | ₹40 Cr |
Total Current Assets | ₹2,273 Cr | ₹1,599 Cr | ₹1,325 Cr | ₹1,894 Cr | ₹1,276 Cr |
Net Current Assets (Including Current Investments) | ₹985 Cr | ₹974 Cr | ₹869 Cr | ₹1,207 Cr | ₹760 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹4,677 Cr | ₹4,098 Cr | ₹3,069 Cr | ₹2,572 Cr | ₹2,017 Cr |
Contingent Liabilities | ₹132 Cr | ₹105 Cr | ₹49 Cr | ₹54 Cr | ₹74 Cr |
Total Debt | ₹357 Cr | ₹548 Cr | ₹26 Cr | ₹33 Cr | ₹29 Cr |
Book Value | - | 304.83 | 268.04 | 234.17 | 185.75 |
Adjusted Book Value | 179.35 | 152.42 | 134.02 | 117.09 | 92.87 |
Compare Balance Sheet of peers of JB CHEMICALS & PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JB CHEMICALS & PHARMACEUTICALS | ₹29,465.7 Cr | 3.9% | 10.5% | 30% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics |
JB CHEMICALS & PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JB CHEMICALS & PHARMACEUTICALS | 3.9% |
10.5% |
30% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses